Novel compound heterozygous mutations in il-7 receptor α gene in a 15-month-old girl presenting with thrombocytopenia, normal t cell count and maternal engraftment

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with severe combined immunodeficiency (SCID) exhibit T lymphopenia and profound impairments in cellular and humoral immunity. IL-7 receptor α (IL-7Rα) deficiency is a rare form of SCID that usually presents in the first months of life with severe and opportunistic infections, failure to thrive and high risk of mortality unless treated. Here, we reported an atypical and delayed onset of IL7Rα-SCID in a 15-month-old girl presenting with thrombocytopenia. Immunological investigations showed a normal lymphocyte count with isolated CD4-penia, absence of naïve T cells, marked hypergammaglobulinemia, and maternal T cell engraftment. Targeted next generation sequencing (NGS) revealed two novel compound heterozygous mutations in the IL-7Rα gene: c.160T>C (p.S54P) and c.245G>T (p.C82F). The atypical onset and the unusual immunological phenotype expressed by our patient highlights the diagnostic challenge in the field of primary immunodeficiencies (PID) and in particular in SCID patients where prompt diagnosis and therapy greatly affects survival.

Original languageEnglish
Article number2471
JournalFrontiers in Immunology
Volume10
Issue numberOCT
DOIs
Publication statusPublished - Jan 1 2019

Keywords

  • Atypical onset
  • IL-7Rα gene
  • Maternal engraftment
  • Novel compound heterozygous mutations
  • SCID

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Novel compound heterozygous mutations in il-7 receptor α gene in a 15-month-old girl presenting with thrombocytopenia, normal t cell count and maternal engraftment'. Together they form a unique fingerprint.

Cite this